EWW-26305-35609
1 vaccination
3 coded responses
12 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 309 / GA
- Registered
- 2021-04-01
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-30
Dose 1 — Moderna
-
2021-04-01
Registered in v-safe
-
2021-04-01
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-02
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-03
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-04-04
- 2021-04-05
- 2021-04-07
-
2021-04-13
Survey response — day 14, dose 1MedDRA: Injection site erythema, Injection site pain — Feeling: GoodFree text: A very faint red spot appeared on my arm at the injection site yesterday (13 days after my first shot), but is getting better. It is about 2 inches in length, and 1 inch wide. There was very slight soreness if I applied pressure.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-22
-
2021-04-29
Survey response — day 28, dose 1MedDRA: Pre-existing disease, Sinusitis — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: I am recovering from a severe sinus infection that was brought on by seasonal allergies, I am on doxycycline, an anti-nausea, and a nasal spray so I had to postpone my second shot. I will be getting it on May 4.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-29
Report sent to call center — day 28, dose 1Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-29
- 2021-09-28
-
2022-03-30
Survey response — 12 months, dose 1MedDRA: Biopsy, Biopsy endometrium normal, Fatigue, Office visit, Postmenopausal haemorrhage, Premenstrual syndrome, Uterine leiomyoma — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Post-menopausal bleeding that began 16 days after booster. Ultrasounds and endometrial biopsy show no sign of malignancy, however, a fibroid was found. Also had full-on PMS that began 14 days after booster. Awful fatigue. · Healthcare visit (other): OB/GYN - 2 ultrasounds, 1 biopsy (neg)MedDRA releases: 2024-11 · check-in free text available
-
2022-03-30
Report sent to call center — 12 months, dose 1Get care from a doctor or other healthcare professional1 call case(s)
-
2022-03-31
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-30 | Moderna |
Call center
2 call center cases
2 successful
Free text
Release 7 — day 14, dose 1
Symptoms: A very faint red spot appeared on my arm at the injection site yesterday (13 days after my first shot), but is getting better. It is about 2 inches in length, and 1 inch wide. There was very slight soreness if I applied pressure.
Release 8 — day 28, dose 1
Symptoms: I am recovering from a severe sinus infection that was brought on by seasonal allergies, I am on doxycycline, an anti-nausea, and a nasal spray so I had to postpone my second shot. I will be getting it on May 4.
Release 11 — 12 months, dose 1
Symptoms: Post-menopausal bleeding that began 16 days after booster. Ultrasounds and endometrial biopsy show no sign of malignancy, however, a fibroid was found. Also had full-on PMS that began 14 days after booster. Awful fatigue.
Healthcare visit (other): OB/GYN - 2 ultrasounds, 1 biopsy (neg)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Biopsy | · | · | ✓ |
| HCVO | Office visit | · | · | ✓ |
| SD | Biopsy endometrium normal | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Injection site erythema | ✓ | ✓ | ✓ |
| SD | Injection site pain | ✓ | ✓ | ✓ |
| SD | Office visit | · | · | ✓ |
| SD | Postmenopausal haemorrhage | · | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Premenstrual syndrome | · | · | ✓ |
| SD | Sinusitis | ✓ | ✓ | ✓ |
| SD | Uterine leiomyoma | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release